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CHARACTERIZATION OF THE NEW XOFT AXXENT ELECTRONIC BRACHYTHERAPY
SOURCE USING PRESAGETM

Jennifer Sierra Irwin, B.S.
Advisory Professor: Geoffrey S. Ibbott, Ph.D.

With continuing advances in the burgeoning field of electronic brachytherapy, an
accurate method of 3D dosimetry is needed to ensure understanding of dose distributions,
which can improve patient care. The aim of this study was to characterize the Xoft Axxent
electronic brachytherapy source using PRESAGETM dosimeters in order to obtain
independent confirmation of TG-43U1 dosimetry values, as well as to further add to the
literature of both Xoft and PRESAGE.
PRESAGE is a polyurethane-based solid 3D dosimeter doped with a radiochromic
leuco dye which produces a linear change in optical density when exposed to radiation.
This optical density change is imaged using an optical-CT scanner and reconstructed for
analysis using MATLAB software. A Xoft source with a measured air kerma strength of
126095 U was used in this experiment to irradiate 8 PRESAGE dosimeters to 15 Gy at 1
cm in order to evaluate the dose rates from r=1 cm to r=5 cm. The dosimetric parameters
were calculated and compared to the Rivard et al. (1)(1) parameters.
In general, the measured results closer to the source more closely matched the
comparison data than those values measured further from the source. The radial dose
function was within 6% of the expected values, and the anisotropy function, ignoring the
extreme outlier at each radius, was within 35% of the expected values. An incorrect shutter
value was used when imaging the dosimeters so that the post-irradiation scans were
repeated 2 months after the irradiation, allowing time for the dosimeter to darken as it aged,
which increased background noise, and time for the dose signal to fade, thereby bringing
the dose signal closer to the background noise. The experiment should be repeated to
obtain more accurate results.
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1 Introduction
1.1 Statement of Problem
1.1.1 General Problem Area
With advances in radiotherapy technology leading to the delivery of more conformal
doses to smaller treatment volumes (2, 3), quality assurance (QA) of such delivery and
equipment has become more important. Currently, 1D and 2D QA methods are used to
sample dosimetric data in 3D volumes. Dosimetry is performed so the radiation dose given
to a patient can be accurately measured, but this is innately a 3D problem, wherein the
radiation interacts with atoms within the patient’s body in all directions, and should therefore
have a 3D method of measurement. 1D and 2D systems have been used effectively, but
can have volume average, artifacts, and energy dependence. The advantage of 3D
dosimetry is that a complete dose distribution can potentially be measured in a single
irradiation; this is impractical for TLD irradiations, and film only provides one plane at a
time. 3D dosimetry can conceivably save the physicist valuable time.
The need for a 3D dosimeter is accentuated when considering brachytherapy, or
short range therapy, where small radioactive sources are placed directly within the
treatment site, creating sharp dose fall-off regions. The dose in these regions is difficult to
measure accurately using conventional dosimetry systems. For example, it is difficult to
accurately measure steep dose gradients using 1D dosimeters such thermoluminescence
dosimeters, due to their finite size and volume-averaging effects(4); and some 2D
dosimeters such as film are subject to artifacts from handling, dependence on energy, and
possibly dependence on dose rate (at the extrema of dose and dose rate) (5). Dose
measurements are required to characterize brachytherapy sources for patient treatmentplanning calculations.
1.1.2 Specific Problem Area
PRESAGETM is a new type of 3D dosimeter which addresses some of the problems
of 1D and 2D dosimeters(6) mentioned above. PRESAGE has been used to determine
dose distributions from a linear accelerator(6), low dose rate (LDR) brachytherapy
sources(7), as well as high dose rate (HDR) brachytherapy sources(8).
In the last decade, a new electronic brachytherapy source, Xoft Axxent (Xoft, Inc., a
subsidiary of iCAD, San Jose, CA) has been studied for use in partial breast irradiation
(PBI) treatments for breast cancer. Xoft has also been studied for use in skin treatments
and in vaginal cancer treatments as a replacement for 192Ir(9). Although many Xoft
applications have been studied since its introduction (10-12), there is only one published
1

paper that provides TG-43U1 dosimetry data for the source (1). PRESAGE has not yet
been used to characterize this new HDR system.
1.2 Background
1.2.1 Brachytherapy
Brachytherapy, or short range radiotherapy, is a method of radiation treatment
wherein a radioactive source is placed in or near a tumor and the radiation from the
decaying source causes damage to the tumor cells, often while sparing more surrounding
normal tissue than external beam radiotherapy (13). Generally, brachytherapy uses sealed
radioactive sources, radioactive material encapsulated within a metal wall, to deliver this
form of treatment. It can be delivered interstitially, inside a cavity (intracavitary), or to the
surface of a patient. Cancers that are commonly treated with brachytherapy are skin,
breast, prostate, vaginal, cervix, and eye.(14)
There are advantages to brachytherapy over external beam radiotherapy. First,
brachytherapy involves placement of sources in or close to the target tissue, maximizing the
tumor dose and minimizing the dose to surrounding normal tissue. Second, brachytherapy
has a lower dose rate when compared to external beam radiotherapy. The lower dose rate
can be exploited, as will be explained below.
Brachytherapy was first performed with radium sources, and later, radon, cobalt,
tantalum, gold, and americium. Today, these sources have been replaced by cesium,
iodine, iridium, and palladium (15). Brachytherapy, using the various isotopes, will either be
classified as low dose rate (LDR) or high dose rate (HDR) depending on the ICRU
definition. The International Commission on Radiation Units (ICRU) and Measurements
Report 38 (16) defines three main categories of dose rate: high, medium, and low, as
described in Table 1.

Dose Rate Category

Dose Rate (Gy/hr)

Low Dose Rate (LDR)

.04 - 2

Medium Dose Rate (MDR)

2 - 12

High Dose Rate (HDR)

>12

Table 1. Dose rate categories from ICRU Report 38 (16)
Table 2 contains the most commonly used radioisotopes in each dose rate category, along
with their dose rate, half-life, and gamma-ray energy range.
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Dose Rate

Half-life

γ-ray Energy

LDR

432.2 years

13.9-59.5 keV

Cs

HDR/LDR

30.0 years

662 keV

Co

HDR/LDR

5.26 years

1.17-1.33 MeV

LDR

2.7 days

0.41-1.09 MeV

125

I

LDR

59.4 days

35.5 keV

192

Ir

HDR/LDR

73.8 days

0.14-1.06 MeV

103

Pd

LDR

17.0 days

20-22.7 keV

226

Ra

LDR

1622 years

0.05-2.4 MeV

222

Rn

LDR

3.83 days

0.05-2.4 MeV

LDR

115 days

0.04-1.45 MeV

Isotope
241

Am

137
60

198

Au

182

Ta

Table 2. Common brachytherapy radionuclides and their characteristics (14, 15)
LDR brachytherapy involves placement of sources within or adjacent to the tumor
for an extended period of time, often several days and in some cases, permanently. The
low dose rate allows normal tissue to perform repair during the treatment, in contrast with
fractionated external beam therapy where repair takes place between treatment fractions.
At the same time, however, the continuous dose delivery allows the total dose, or a large
fraction of the dose, to be delivered in a shorter elapsed time, thereby minimizing tumor
repopulation effects.
In contrast, HDR brachytherapy combines the shorter overall treatment time and
dose localization capabilities of LDR brachytherapy with the benefits of hypofractionated
external beam therapy. With HDR, normal cells have time between treatment fractions to
repair sublethal damage. (13)
AAPM TG-43U1(17) discusses how to calculate the dose from brachytherapy
sources, and AAPM TG-56 (18) discusses how to calibrate brachytherapy sources. TG43U1 will be discussed in detail in Chapter 2, and TG-56 will be briefly explained here for
the most common HDR source, 192Ir. The HDR iridium source has no national standard;
however, an interpolation can be made between 137Cs and orthovoltage energies. As an
interim standard, the interpolative free air secondary standard method is now accepted.
(19) To perform this calibration, air kerma rate measurements are taken along the z-axis of
the source from 10 to 100 cm away with an ion chamber in a free air geometry. (Section 2.4
and Figure 21 provide a detailed description of the TG-43U1-defined coordinate system.)
The ion chamber should have a buildup cap thick enough to ensure secondary electron
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equilibrium. The 192Ir air kerma calibration factor is derived by interpolating between the
137

Cs and orthovoltage air kerma factors, which are Accredited Dosimetry Calibration

Laboratory (ADCL) or National Standards Institute of Technology (NIST) traceable. It
should be noted that this calibration procedure is not recommended to be performed by
clinical medical physicists, but rather by the trained calibration laboratory personnel. This
procedure is only noted here for comparison with the Xoft Axxent calibration procedure.
Both AAPM TG-56 and AAPM TG-59 (20) discuss how to perform a standard HDR
treatment. This is discussed here very generally, again, for comparison with a Xoft Axxent
electronic brachytherapy treatment. An HDR source is at the end of a long wire, which is
kept within the shielded afterloader. The patient is setup with the catheter in place, within
the appropriate applicator, as is applicable to the treatment. The personnel leave the room
and operate the afterloader from outside the treatment vault. When the treatment begins,
the source, on its wire, moves out of the afterloader and down into the catheter, and into the
patient. Various dwell positions and dwell times of the HDR source, as determined with the
treatment planning system (TPS) to achieve the desired dose to the tumor, are controlled
by the HDR console during treatment.
1.2.2 Electronic brachytherapy
In response to complicated intraoperative radiotherapy procedures and
requirements, as well as the inconvenience of dealing with radioactive materials regulations
and security requirements, small, mobile, low kV x-ray sources were developed in the late
1990s. (21) These sources have since been co-opted by the brachytherapy community.
Their low energy x-rays greatly minimized exposure to the staff, though their usage is
currently limited to small tumors. The Xoft Axxent system was ostensibly developed to
mimic the treatment energies of HDR 192Ir so it could be directly substituted into many
current cancer treatment techniques.
AAPM TG-61 (22) covers low energy x-ray calibration and dosimetry. This is
typically used for superficial and orthovoltage machines, but, the Xoft User’s Manual (22)
states that it should be applied in the interim while an AAPM task group report is being
prepared on electronic brachytherapy. Low kV x-ray calibrations should be traceable to a
national standard, either NIST or an ADCL, and are performed in air, to obtain the air kerma
strength.
1.2.2.1 Xoft
Xoft Axxent is an electronic brachytherapy system that consists of an electronic
controller, a miniature electronic x-ray source inside a flexible catheter (shown in Figure 1),
4

and a balloon applicator. The x-ray tube inside the catheter is water-cooled with sterile
water; the x-ray tube inside the catheter is shown in Figure 2. The catheter is 250 mm in
length and 5.1-5.4 mm in diameter. (23)

Figure 1. Xoft Axxent source in its shipment box.

Figure 2. Drawing of inside the Xoft catheter.(1)
The Xoft source can deliver dose at voltages of 40 kV, 45 kV, and 50 kV. The
average energy of the Xoft spectrum at 50 kV is 26.6-26.7 keV. The dose rate is expected
to be 0.6 Gy/min at 3 cm from the source axis.
The power requirement for the Xoft Axxent device is 15 W. The maximum beam
current is 300 µA, but is adjustable for treatment. The x-ray tube can be stepped to different
5

dwell positions within the catheter at millimeter intervals and for different dwell times, just as
conventional HDR sources can be. The manufacturer recommends that each Xoft source is
disposed of after whichever of the following occurs first: 10 fractions, 170 minutes of
treatment time, or 35 days after the initial calibration, provided the cooling water is
vacuumed out after each use. (24) All sources are disposable. The Xoft system complies
with the International Electrotechnical Commission (IEC) medical electrical safety
equipment standard 60601-2-17. (25)

Figure 3. Xoft Axxent electronic brachytherapy system controller (24)
Both BrachyVision and Plato TPS have been verified for use with the Xoft Axxent
electronic brachytherapy source. If an electrical malfunction occurs during the treatment, as
mandated by the IEC (25), the controller, shown in Figure 3, will stop the treatment and
record the treatment values at that time. The display shows dwell position, and total
planned time, elapsed time, and time left at current dwell position; the display screen, as
part of the system controller, is shown in Figure 3.
Air kerma strength is measured by the manufacturer prior to shipment, and again by
the physicist prior to each fraction. Before each clinical treatment, the air kerma strength of
the source is measured and compared to the “nominal” air kerma strength, which was
determined when the system was initially calibrated and is used to create treatment plans.
A ratio of the “nominal” to the measured air kerma strength is used to adjust the dwell times
6

in the TPS. The air kerma strength is measured in the attached Standard Imaging well
chamber and electrometer (Models HDR 1000 Plus and MAX-4000, respectively (Standard
Imaging, Middleton, WI)) using a custom insert that attenuates the source. The purpose of
this insert is threefold: 1) it shields the source so personnel may remain in the treatment
room while calibrating, 2) it absorbs the lower energy photons that would be absorbed in
the applicator during treatment, and 3) it reduces the source output so it is within the
operating range of the electrometer. This well chamber, insert, and electrometer system
must be calibrated by an ADCL every two years.
The well chamber calibration for this source has no NIST standard procedure;
however, the ADCL at the University of Wisconsin (UW) developed a secondary calibration
method combining methodology described in both TG-43U1 and TG-61 (Report 79) on low
energy x-ray dosimetry. The calibration coefficient for the well chamber is based on a
comparison of the I-125 national standard and the measurement of the Xoft Axxent source
using an Attix free-air chamber (FAC) at the UWADCL (University of Wisconsin Accredited
Dosimetry Calibration Laboratory). First, a well chamber calibration coefficient C is obtained
for I-125, resulting in air kerma strength per corrected well chamber current unit (U/A). Next,
the output of the Xoft source is measured in the FAC, and then in the well chamber; a
calibration coefficient is obtained for Xoft. The ratio R is defined as the ratio of the Xoft
calibration coefficient to C, the I-125 well chamber calibration coefficient. C times R results
in NSK, or the air kerma strength well chamber calibration coefficient for Xoft. This is the
“nominal” SK used in the TPS; SK is air kerma strength in U, and its full TG-43U1 definition
is provided in Chapter 2. The manual describes a “compensated” air kerma strength value,
which is the air kerma strength corrected for temperature and pressure. (24)
Each patient receives their own disposable Xoft source. To deliver a treatment, the
source is connected to the high voltage and water-cooling systems, calibrated in the well
chamber, then finally inserted into the applicator in the patient. The operator may stay in the
room during the treatment, due to the low energy nature of the x-rays produced by the Xoft
source. This is an advantage to treating with Xoft. For example, for a breast cancer
treatment, a 0.4 mm lead equivalent shield placed over the patient’s breast will reduce
exposure from 15 mR/h to 1 mR/h at the operator’s location. However, the resulting
scattered radiation will increase the dose to the patient. To further reduce exposure,
personnel may wear lead-equivalent aprons. This also drastically reduces the room
shielding requirements. (23)
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TG-152 (publication date unknown) has been assigned to address clinical
application and quality assurance procedures for electronic brachytherapy sources,
including the Xoft Axxent system.
1.2.2.2 Previous Xoft Studies
Xoft has been studied as an alternative accelerated partial breast irradiation (APBI)
method (10, 26), in nonmelanoma skin cancer treatment (12), and in endometrial cancer
treatment (10). These studies were performed to compare Xoft with the current accepted
treatment method, the 192Ir HDR source, in effectiveness and dose coverage. There have
been poster displays describing the Xoft dosimetry as determined using MOSFET(27), film
(28, 29), ion chambers(29), an x-ray spectrometer(29), and solid and liquid water (30), as
well as Monte Carlo simulations (30-32), but the Rivard et al. paper (1) is the only published
source that provides the TG-43U1 dosimetry parameters. It should be noted that these
posters were all done in part by a Xoft employee, and so technically violate the TG-43U1
recommendation that “independent and redundant dosimetric characterizations” be
performed for every new brachytherapy source intended for clinical use.
Rivard et al. used both Monte Carlo simulations and liquid water measurements with
a PTW parallel plate ionization chamber to characterize the source. The Monte Carlo
simulations were based on the MCNP5 code and the EPDL97-based mcplib04 crosssection library. TG-43U1 parameters (radial dose function, anisotropy function) were
determined for radial distances between 0.4 cm and 15 cm, and angles between 0° and
175°. Ion chamber measurements were made many locations corresponding to the
calculation points. Operating voltages of 40 kV, 45 kV and 50 kV were used for simulations
and measurements. The Rivard et al. data was used to create the Xoft User’s Manual.
Characterizing the Xoft source with PRESAGE is a novel experiment, and would add
independently-derived dosimetry data to the existing body of knowledge. A better
understanding of Xoft dosimetry can be used to more accurately treat patients.
1.2.3 PRESAGE Dosimeters
1.2.3.1 Gel Dosimetry
PRESAGE (Heuris Pharma LLC) was introduced in 2003 as an alternative to gel
dosimeters. Gel dosimetry was first explored in the 1950s; the first radiosensitive gels were
doped with a dye and would change color due to a chemical reaction when exposed to
radiation. The next type of gel dosimeter was doped with chloral hydrate, which reacted to
radiation; the change in the gel could be observed using pH probe measurements or
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spectrophotometry. In the 1980s, the chemical reaction to radiation in Fricke gels, which
were doped with ferrous sulfate, could be imaged with an MRI machine.
Another type of gel dosimeter, now more common, is the polymer gel dosimeter,
which would polymerize as a function of dose when exposed to radiation. The
polymerization could be measured using MRI, optical-CT, x-ray CT, or ultrasound. BANANA
(made of bis-acrylamide in an aqueous agarose matrix, nitrous oxide, and agarose) and
BANG (made of bis-acrylamide in an aqueous agarose matrix, nitrogen, and aqueous
gelatin) gels are examples of polymer gels. The optical-CT scanner developed for use with
these gels was a precursor to the optical-CT scanner used in this project. (33)
There are drawbacks to using gel dosimeters. First, they are oxygen-sensitive;
oxygen inhibits the polymerization process. Polymer gels must be manufactured and stored
in an oxygen-free environment, which is not practical in a clinical setting. Next, gels must be
stored in a container, but imaging the container results in edge artifacts, even when steps
are taken to minimize these effects via refractive index matching fluid. In Fricke gels,
diffusion of the ions caused a loss of spatial resolution and an unstable dose distribution.
Other types of gels do not have the same diffusion issue. Lastly, when using optical-CT to
image gel dosimeters, light scatter artifacts become an issue. PRESAGE addresses these
issues, as explained in the next section. (34)
1.2.3.2 Characteristics of PRESAGE 3D Dosimeters
When exposed to radiation, PRESAGE dosimeters produce an optical density
change that can be imaged with an optical-CT to determine dose. A PRESAGE dosimeter,
as seen in Figure 4, is a polyurethane-based dosimeter that is doped with leucomalachite
green (LMG) dye which reacts linearly to radiation dose, regardless of photon energy and
dose rate. (6) Halocarbon free radical initiators respond to high energy radiation, and in so
doing, oxidize the LMG, creating the change in OD. The sensitivity of the dosimeter
depends on the type of halogens used in the initiator. (35) The oxidation of the LMG dye
creates a stable signal in PRESAGE. However, some current experimental formulations of
PRESAGE are attempting to create a reusable dosimeter and so do not allow a lasting
stable signal. Different PRESAGE formulations are made to be more sensitive to different
types of radiation, e.g., photons versus protons.
-
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Figure 4. Example of an irradiated solid 1 kg PRESAGE dosimeter.
PRESAGE was created so the user can acquire a 3D volume of data from a single
irradiation. PRESAGE is imaged using an optical-CT scanner, which provides the user with
the optical density changes in the dosimeter which are used to determine dose. (6) The
resolution of PRESAGE depends on the resolution of the scanner used to image it (see
section 1.2.3.2 for more information). Its effective Z is ~7.7, which closely mimics that of
soft tissue or water (Zeff ~ 7.4, in both cases). The density of PRESAGE is 1.05 g/cm3,
which compares well with that of water. (36) PRESAGE, unlike gel dosimeters, is not
oxygen sensitive and requires no external container. With PRESAGE, there is no diffusion
of the dye, and it can be synthesized into different shapes and sizes. PRESAGE is,
however, light and heat sensitive.
Although PRESAGE is currently best used as a relative dosimeter, an absolute dose
calibration curve can be created for each batch of PRESAGE using cuvettes containing the
PRESAGE material. The cuvettes are irradiated to a range of doses, then the optical
density (OD) is read out. A graph of OD change versus dose in Gy is created and can be
used to scale the larger PRESAGE dosimeters from that batch to an absolute dose. The
calibration curve illustrates that the change in OD is linear with dose. The calibration curve
can account for signal changes post-irradiation; it has been shown that the “standard”
formulation signal can fade by 4% per 24-hour post-irradiation period. (6) With a slightly
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different formulation (the “soft” batch), this signal fading can be accelerated, so that a
dosimeter would be bleached and reusable after a week. Current research in this direction
is ongoing.
1.2.3.3 Drawbacks of PRESAGE
PRESAGE is sensitive to UV and blue light (35). To prevent this sensitivity,
PRESAGE is stored in black, light-tight bags when not in use. Scanning and irriadiating is
performed with the lights out. PRESAGE is also sensitive to temperature. This issue is dealt
with by storing PRESAGE in a refrigerator kept at 4° C. For the entire pre-irradiation scan,
irradiation, post-irradiation scan process, it is recommended that the PRESAGE be kept at
room temperature for accurate dosimetry. (6, 37)
1.2.3.4 Optical-CT Imaging with DMOS
The optical-CT scanner used at the Imaging and Radiation Oncology Core in
Houston (IROC-Houston, formerly the Radiological Physics Center (RPC)) is called DMOS
(Duke Medium-field-of-view optical-CT scanner) and it is shown in Figure 5. The
configuration of the scanner is as follows: a diffuse red LED light shines through the
dosimeter, which is placed in an indexing tank, and on through a lens into a CCD camera.
The aquarium is filled with a mix of octyl salicylate, octyl cinnamate, and light mineral oil to
match the refractive index of the dosimeter at the fluid-dosimeter interfaces; this helps
prevent dosimeter edge effects that blur the optical density signal. (38) The LMG dye used
in PRESAGE was chosen, in part, because its visible absorbance maximum corresponds to
the 633 nm red laser light that was used to optically scan PRESAGE in the first
commercially-available optical-CT scanner. (6) The DMOS has a red LED light of the same
wavelength.
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Figure 5. Diagram of DMOS system's main components.
The dosimeter rotates via an electronic stepper motor base. The lens rejects stray
light that is further than 0.1° off the optical axis. The camera takes line integrals at each
projection angle, which are used to reconstruct a 3D image via filtered backprojection.
LabView is used to collect the images and rotate the dosimeter. An example of the DMOS
Acquisition GUI (Duke University, NC) is shown in Figure 6. The user enters the filename
stem, the file destination, and the scanning parameters. (39) The total scan time for a 1 kg
dosimeter is between 15 and 20 minutes. This is a vast improvement on the first
commercially available optical-CT scanner mentioned previously, which took 7 minutes per
z slice, for a total scan time of a few hours. (40)
Dosimeters are scanned prior to and after irradiation so that background and final
OD can be determined. In general, 720 projection images are taken, one every 0.5°; 8
images are averaged together at each projection angle. A flood image is taken without a
PRESAGE dosimeter in the aquarium to correct for inhomogeneities in both the matching
fluid and LED light field. A dark image is taken to correct for electronic noise. Both the flood
and dark images are 200 averages of one projection image.
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Figure 6. Screenshot of DMOS Acquisition GUI without a dosimeter in the tank.
The spatial resolution of the system depends on user settings and available storage
space for the projection images. Typically, the dosimeters at IROC-Houston are scanned to
have either 0.5 mm or 1 mm voxels. The resolution of PRESAGE can only be as high as
the resolution of the scanner used to image it. The CCD Basler camera captures 12-bit
monochromatic 1040x1392 pixel arrays.
Monochromatic light attenuates exponentially under narrow beam conditions, as
exist in the DMOS. The optical-CT readout of a dose response in PRESAGE is explained
by this 2D, i.e., per projection angle, equation:
𝐼(𝑥) = 𝐼0 𝑒 − ∫ 𝜇(𝑥,𝑦)𝑑𝑦

Eqn. 1

Here, I0 is the incident intensity of the light hitting the dosimeter, I(x) is the intensity of the
light exiting the dosimeter at position x, and µ(x, y) is the optical attenuation coefficient per
unit length. (33) From this equation, we can calculate the OD, or absorbance, of the
dosimeter with this equation:
𝑂𝐷 = − log (𝐼⁄𝐼 ) (7)
0

Eqn. 2

This is what is calculated and saved in the 3D data cube matrix output from the
Reconstruction software. From the OD, the dose can be calculated, either by the cuvette
calibration curve, or the following equation:
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𝐷𝑜𝑠𝑒 = −

𝑂𝐷
𝑠 × 𝑥

Eqn. 3

where OD is defined previously, s is the sensitivity (∆OD/Gy/cm) and x is the irradiated path
length in cm. If relative dose is all that is needed, the data cube is normalized to a userspecified dose delivered at a user-specified location.
Reconstruction of the projection images is completed using the DMOS software; a
screenshot of the Reconstruction GUI is shown in Figure 7. First, the pre-irradiation and
post-irradiation optical-CT scan images are each loaded together with a flood image and a
dark image to make the corresponding corrections for background noise. To create the
sinogram, a 5x5 kernel median filter is applied to reduce noise, and a 1 mm voxel size is
selected for reconstruction. As part of this process, the pre-irradiation scan image is
subtracted from the post-irradiation scan image to obtain a net change in the dosimeter. In
the end, a series of 2D sinograms is generated.
A sinogram is a single image of all the raw data acquired by the CT scanner; an
example sinogram can be seen in the top right corner of Figure 8. The horizontal axis of the
sinogram represents each angle at which a projection image was taken; for this experiment,
a projection image was taken every 0.5° from 0° to 360°. The vertical axis of the sinogram
represents the projection images taken; 720 projection images were taken in this
experiment. Filtered backprojection (FBP) is an iterative reconstruction technique which
uses the sinogram to reconstruct a 3D tomographic image of the original scanned object; it
is the “computed” in CT’s computed tomography.
To perform FBP, the backprojection is completed first. Backprojection reverses the
image acquisition steps, taking the linear optical attenuation coefficient µ for each
projection, and “smearing” it back along the angle at which the projection image was taken
into its position in an empty image matrix; backprojection will fill the image matrix. In this
manner, the high attenuation areas reinforce each other, as do the low attenuation areas,
creating a 3D reconstructed image representation of the original object scanned. A filter is
applied to correct the 1/r blurring caused by reconstructing an image using
backprojection.(41)
The DMOS Reconstruction GUI, seen in Figure 7, reconstructs the final 3D opticalCT image of the dosimeter via filtered backprojection; the “iradon” function in MATLAB
performs the backprojection, and the RAM LAK filter smoothes out the blurriness (42). The
user selects the center of rotation (COR) to reconstruct around, and the size of the data
cube in mm, which should be slightly larger than the physical dosimeter size. The final 3D
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“image” is saved as a data cube, which is the input for the radial and anisotropy data
extraction scripts. (39)

Figure 7. Screenshot of the DMOS Reconstruction GUI.

1.2.3.5 Previous work with PRESAGE
PRESAGE has been used to check IMRT dose distributions, and was found to be
accurate to within 3%/3mm when evaluating dose distributions using the gamma index. (43)
A gamma index comparison between EBT film, PRESAGE, and software-calculated dose
distributions found three-way agreement to be within 4%/4mm. (40) An investigation of
PRESAGE to measure doses in the RPC head and neck (H&N) phantom yielded
acceptable results; a gamma index comparison between Eclipse, PRESAGE, and EBT was
within 4%/4mm for that experiment (44). PRESAGE has been investigated for use with
radiosurgery treatment systems; Niebanck found less than 3% standard deviation of dose in
the target (3) and Clift et al. measured scatter factors in PRESAGE that agreed with ion
chamber measurements within 4% for every field (45). PRESAGE has also been
investigated as a new way to perform IMRT QA, with a 94.9% passing rate for a 3%/2mm
gamma index. (46) PRESAGE was used to obtain TG-43 dosimetric parameters for the 192Ir
source, with a percentage of standard deviation between PRESAGE and published results
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of 2.6% or less. (8) This will be the first time PRESAGE has been used to characterize an
electronic brachytherapy source.
1.3 Hypothesis and Specific Aims
We hypothesize that PRESAGE dosimeters can measure, with 95% confidence, the
AAPM TG-43U1 dosimetric parameters of the Xoft Axxent electronic brachytherapy source,
to within 5% and 3mm of published values.
The specific aims for testing this hypothesis:
1. Write code specifically for use with PRESAGE dosimeters in MATLAB to extract
data for TG-43U1 analysis.
2. Determine the TG-43U1 parameters of the Xoft Axxent electronic brachytherapy
source using PRESAGE dosimeters. TG-43U1 parameters will be extracted from the optical
scans of the irradiated dosimeters via the code developed in Specific Aim 1.
3. Compare PRESAGE-measured TG-43U1 parameters for the Xoft Axxent
electronic brachytherapy system with published parameters.
2 Methods & Materials
2.1 Dosimeter Design
Two formulations of PRESAGETM were irradiated with the Xoft source - a "soft"
batch (#46), and a "hard" batch (#45. According to the manufacturer, the difference
between the two formulations is the polyurethane used - soft versus hard. The soft batch is
more tissue-equivalent, but will bleach over time (a new experimental formula), and the
hard dosimeters are the usual PRESAGE formulation. The dosimeters are approximately 1
kg, 12 cm in height, and 11 cm in diameter. Due to the size of the DMOS tank and the fieldof-view of the DMOS camera, the dosimeters cannot be much larger than this. The size of
the dosimeters also limits the maximum radius to which the dose can be measured to
approximately 5 cm.
Both formulations of PRESAGE were cast with two different channel sizes, as seen
in Figures 8-9. The two channel sizes were first suggested by Olivia Huang's research
using AgX100 I-125 seeds (7). She found that because PRESAGE reacts linearly to dose, a
large dose near the source will cause a great change in OD, such that when the dosimeter
is optically CT-scanned, imaging through the center becomes difficult since the dye is so
dark there. However, if the dosimeter is irradiated with the source in a PRESAGE plug
(seen in Figure 10) in a large channel, the plug may be removed when the dosimeter is
optically CT-scanned, and the center of the dosimeter won’t be as dark since the plug has
been irradiated to the high dose instead of the dosimeter. In Huang’s experiment, a higher
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dose was given to the large channel dosimeters than to the small channel dosimeters so
that the dose at large radii would be readable in the scanner. Likewise, a smaller dose was
given to the small channel dosimeters so that the dose in the center of the dosimeter could
be read by the scanner. This way, the dose throughout the dosimeter could be measured.
However, Huang also found that a higher dose than she used could be given to the
dosimeters, and it was decided that for this experiment, the same, higher dose would be
given to both channel sizes and both PRESAGE formulations.

Figure 8. PRESAGE with 1.5 cm diameter large channel (soft batch).

Figure 9. PRESAGE with 5.3 mm small channel (hard batch).

Figure 10. Irradiated plug for large channel dosimeters; note the darkened end where
the x-ray tube was located within the Xoft catheter within the plug.
For this experiment, the larger channel size was 1.5 cm in diameter, with a
PRESAGE plug, or insert, that fit exactly into the channel to keep the Xoft source secure in
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a homogenous attenuating medium. The plug was removed for imaging, and the channel
was filled with matching fluid. The smaller channel size was 5.1 mm in diameter, sized so
that the Xoft source fit perfectly in place. From Huang's thesis, the smaller channel size was
used to measure doses out to a radius of 2.5 or 3 cm, and the larger channel size was used
to measure doses out to the edge of the dosimeter, at a radius of approximately 5 cm. For
this experiment, however, it was decided that both channel sizes and both formulations
could be irradiated to 15 Gy at 1 cm without any OD read-out issues.
2.2 Treatment setup and delivery
2.2.1 Dose calibration
Five cuvettes containing the soft PRESAGE formulation and ten cuvettes containing
the hard PRESAGE formulation were requested from the manufacturer along with the 1 kg
dosimeters used for this experiment. Cuvettes, seen in Figure 11, are small plastic vials,
approximately 1 cm square and approximately 5 cm long, containing PRESAGE. Cuvettes
are used to determine absolute dose for different PRESAGE batches, since PRESAGE is a
relative dosimeter.

Figure 11. PRESAGE cuvettes for dose calibration.
Prior to irradiation, the cuvettes were labeled (S1-S5 and H1-H10) and their
absorbance at 633 nm was determined in a Genesys 20 spectrophotometer (Thermo
Scientific, Waltham, MA). This established a background optical density. The cuvettes were
scanned in two directions to ensure the optical density was approximately the same
throughout.
The cuvettes were irradiated with an orthovoltage machine at 125 kVp, which has a
dose rate of 74.76 cGy/min. The cuvettes should have been irradiated at 75 kVp, the beam
closest to the 50 kVp Xoft energy characterized and available at this institution. However,
the cuvettes were inadvertently irradiated with the 125 kVp beam instead. The doses to the
cuvettes were originally calculated assuming the 75 kVp beam, but when the error was
realized, the doses were recalculated.
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For the irradiation setup, the cuvettes were placed on top of approximately 10 cm of
solid water to prevent backscatter, and within an acrylic sheet with a cutout in the center
large enough to place four cuvettes side-by-side. Any gap within the acrylic sheet was filled
with previously irradiated cuvettes for consistent material densities. This setup can be seen
in Figure 12. The SSD was 50 cm, the field size was 10 cm by 10 cm, the irradiation was to
the surface, and the dose was calculated to muscle.

Figure 12. Cuvette irradiation setup (7).
The cuvettes were given half their total dose on one side, then turned over 180° and
irradiated to the rest of the dose. This was to ensure that the cuvettes were evenly
irradiated to the total dose, so the dose profile would not have any steep gradients. The
cuvettes were irradiated to an evenly-spaced range of doses, as seen on the x-axes in
Figures 13-14, with one held aside so a “zero” dose mark could be obtained. The cuvettes
were irradiated to different doses so a dose calibration curve could be obtained - OD versus
dose.
After irradiation, the cuvettes were scanned in the same spectrophotometer at 633
nm, again in two directions, and the ODs recorded. A graph of OD versus dose was created
for both batches of cuvettes, as seen in Figures 13-14. Net OD was calculated by
subtracting the average of the pre-irradiation scan ODs from the average of the postirradiation scan ODs.
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Figure 13. Hard dosimeters dose response curve with a linear fit and corresponding
R2 value.

Soft dosimeters Dose Response
0.700

y = 0.0072x + 0.0221
R² = 0.9701

0.600

OD/cm

0.500
0.400
0.300
0.200
0.100
0.000
-0.100

0

10

20

30
Dose (Gy)

40

50

60

Figure 14. Soft dosimeters dose response curve with a linear fit and corresponding
R2 value.
2.2.2 Pre-irradiation
The dosimeters were stored in black bags in a refrigerator kept at 4° C; PRESAGE
is light and heat sensitive, and this procedure reduces background exposure of the
dosimeters. Prior to scanning or irradiation, the dosimeter was removed from the fridge and
allowed to warm up to room temperature for at least six hours.
Eight total dosimeters were used in this experiment, four of the hard formulation,
and four of the soft. Of the four hard dosimeters, one had a large channel, and three had a
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small channel. Of the four soft dosimeters, two had a large channel, and two had a small
channel. The dosimeters all had a small base glued on the bottom so they could be
reproducibly placed and scanned in the DMOS. Since there were two different formulations,
two different refractive index (RI) matching fluid compositions had to be created prior to the
pre-irradiation scans. The soft dosimeters were scanned first; mineral oil was used to lower
the RI to approximately 1.485. Next, the hard dosimeters were scanned; cinnimate was
added to the tank to raise the RI to approximately 1.495.
Since UT MD Anderson does not have a Xoft source, after the dosimeters were preirradiation scanned to obtain a measurement baseline, they were shipped in a light-tight box
to the UWADCL.
2.2.3 Treatment delivery
The Xoft Axxent controller is used to deliver treatment in the clinic. However, for this
experiment, a Modulation Test Fixture (MTF), seen in Figure 15, provided by the
manufacturer to the UWADCL was used. It mimics the electronic controller and TPS; it
allows the user to adjust the tube voltage and current, among other settings. The MTF uses
a Monte Carlo software package to create "treatment plans," which allow time for the
source voltage and current to ramp up and ramp down. Well chamber measurements can
be made in either the provided Standard Imaging shielded well chamber (identical to the
one provided with the commercial unit) or the NIST-calibrated Standard Imaging well
chamber; for this experiment, measurements were taken in the NIST-calibrated well
chamber.
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Figure 15. MTF at UWADCL.
Due to the complicated procedures required to run the MTF, the staff at UWADCL
ran the unit according to the irradiation time calculation provided to them. The irradiation
time calculations had the units minutes per unit air kerma (in U), so that when the well
chamber measurement of the Xoft source was taken, irradiation time was solved for and
then plugged into the Monte Carlo system. The manufacturer gave the air kerma strength of
the selected source, provided by Xoft (Xoft, San Jose, CA), as 126095 U. The UWADCL
calibrated air kerma strength for this source was 1.180x1012 U/A.
Initially, the calculated treatment time was less than one minute, which would
introduce large ramp up errors into the dose calculations. To lengthen the treatment time,
the weaker of the two provided Xoft Axxent sources was selected for use (SK stated
previously); unfortunately, this only added a few seconds to the total irradiation time. To
further lengthen the treatment time, the treatment amperage was lowered; test protocols
were run at both 200 µA and 100 µA. At 100 µA, the treatment time was three minutes, and
so the ramp error was greatly reduced. Previous (currently unpublished) studies at UW
have shown that operating the source at these lower currents is an acceptable method to
lengthen treatment times to minimize ramping errors.
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A protocol was created to run at 50 kV and 100 µA for 180 seconds. This procedure
was followed for all 8 irradiations. However, during all of the soft batch PRESAGE
irradiations, the source arced part of the way into the irradiation. A new protocol was
created for each of these cases to irradiate for the remainder of the 180 seconds. This
introduced more ramp up error into the irradiation, but it did not change the total dose
delivered by more than 2.7%.
For the irradiations, the dosimeters were placed in a cylindrical phantom,
approximately 29 cm in diameter. Foam was used to reduce the diameter to approximately
21 cm, then the dosimeter was placed on a base that raised it approximately 5 cm above
the bottom of the phantom. Rice was then poured around the dosimeter, which was still
enclosed in a black bag to protect it from light. The rice, a tissue equivalent material, was
used to produce backscatter that would be comparable to the backscatter of the ion
chamber measurements and the Monte Carlo calculations. Rice was used instead of water
because PRESAGE, particularly soft batch PRESAGE, is partially soluble in water. The
dosimeter was centered in the phantom so that it was surrounded on all sides by
approximately 5 cm of rice. For ease of transfer between dosimeters, a plastic bag was
placed into the tank for the rice to be poured into and out of. This setup is shown in Figure
16.

Figure 16. Dosimeter shielded from light and surrounded by rice in phantom.
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With the room lights out, the Xoft catheter was placed, either directly into the small
channel or into the PRESAGE plug then into the large channel (seen in Figure 17). In either
case, the catheter and plug were inserted to the very bottom of the channel. As stated
previously, all dosimeters were irradiated to 15 Gy at 1 cm with a treatment time of 180
seconds. In the cases when the source arced, the 180 second treatment time was
completed, but the dose was calculated to be closer to 15.41 Gy, due to the additional ramp
up error. The dosimeters were shipped back to IROC-Houston post-irradiation, and
scanned in the DMOS as soon as the experimenter returned.

Figure 17. Xoft Axxent source inside plug inside PRESAGE dosimeter.
2.3 Imaging and analysis
2.3.1 Optical-CT imaging
The dosimeters were scanned post-irradiation according to the methods outlined in
Chapter 1. Due to the two different PRESAGE batch formulations, the RI of the matching
fluid was monitored and adjusted as needed to match the RIs used during the preirradiation scans. Reconstruction of the images was also performed according to the
methods described in Chapter 1.
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2.3.2 Data Acquisition in MATLAB
In an earlier work, to extract the TG-43U1 data from the DMOS optical-CT scans,
the scans were imported into the Computational Environment for Radiotherapy Research
(CERR) and the OD was scaled according to the calibration curve obtained from the
cuvettes. Line profiles were taken, which create a plot of dose versus dosimeter radius, and
parameters were input into an Excel spreadsheet for analysis. Since this is a lengthy
process, only 12 points from each radius were taken and averaged together (7). To make
data extraction faster and simpler, as well as to obtain more points for use in the average
dose, code was written to do this instead.
Two separate scripts were written - one to calculate the radial dose function, called
radialunicorns.m, and the other to calculate the anisotropy function, called
anisotropyunicorns.m. The codes work in similar ways: they both take an average of the
value of the data cube within an annulus. The coordinate system used to define the annulus
in PRESAGE is depicted in Figure 18. The annulus is defined as 3 z-planes thick, centered
around the anode’s z-plane, with the inner and outer radii ±0.5 mm from the defined radius
given by Rivard et al. (1); an example annulus is shown in Figure 19. For the anisotropy
function, averages were also taken every 10° for each given radius. The polar angles noted
were also taken from Rivard et al. (1), for ease of comparison. The entire cube is searched
for points within the annulus.
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Figure 18. Diagram of the transverse plane (red dashed circle) and another
measurement plane at θ (black dashed circle), in the PRESAGE dosimeter.
The average value of the data cube is output as an unnormalized average dose rate
at that radius, or at that radius and angle.
These two codes are written out in Appendix B. To use them, the user must type the
location of the input data cube file in the *.m file so it can be loaded, then run the script.
This data cube is saved from the Reconstruction GUI discussed previously. The script will
ask the user for the (x,y,z) center of the data cube, i.e., the location of the Xoft Axxent
anode, from which point the script will do radius and angle calculations. The z-axis is
defined in the data cube by the DMOS Reconstruction software, and MATLAB uses this
definition when it imports the data cube. The x- and y-axes are less important because the
radius and polar angle calculations are both performed with respect to the z-axis only. The
user will also be asked to enter the size of the data cube (x,y,z). Both of these coordinate
sets can be obtained by running GUIPhoenixFire.m, a code developed by a fellow lab group
member, Slade Klawikowski, to extract dose from CyberKnife PRESAGE irradiations. A
screenshot of the GUIPhoenixFire.m program is shown in Figure 20.
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Figure 19. The image on the left is a top view of the dosimeter showing the annulus
described; the z-axis points into the page. The dashed red line is the radius from
which the delta is applied. The black circle at the center is the channel, and the black
outline is the outer edge of the dosimeter.
Notice the sliders at the bottom of the GUI; the long slider allows the user to page
through the optical-CT slices in z, and the x and y sliders that allow the user to select the
center of the dosimeter. From these three sliders, the user can determine both the (x,y,z)
center and the (x,y,z) extent of the data cube. The center of the dosimeter is not its
measured center, but rather the point in the channel where the anode of the Xoft catheter is
expected to be. When stepping through the z slices of the dosimeter in the PhoenixFire
GUI, the anode was assumed to be in the last slice of the channel, as shown in Figure 20.
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Figure 20. Screenshot of PhoenixFire GUI, showing z slice where anode is located.
The radialunicorns.m code output a MS Excel spreadsheet of the average relative
dose rate within each annulus for each radius. The anisotropyunicorns.m code output a MS
Excel spreadsheet also which contains the average relative dose rate for each radius and
angle pair. The code allows the user to name select where to save the Excel files. The data
within these files is used to calculate the TG-43U1 parameters, which are then compared to
the TG-43U1 parameters given in Rivard et al. (1) for Specific Aim 3.
2.3.2.1 Testing the code
To ensure the scripts written worked correctly, a number of test scenarios were
created where the outcome of the script could be estimated easily by the user. The first test
was sending a data cube matrix of all ones through the script. The output of the script
calculated the average value for each radius annulus as one, as expected. Next, a small
(9x9x9) data cube matrix was created where the value of the data cube was equal to the
radius at that point, e.g., at r=3, the value is 3. This test matrix returned expected results,
i.e., the average value at r=3 was ~3. As a final test, a data cube of similar size to those
used in this project was run through the complete code. The data cube was taken from a
CyberKnife irradiation, and had two peaks, one sharp and towards the top of the dosimeter,
and one broad and flat, towards the bottom. The dose from these irradiations had some

28

angular dependence. The code was run twice, using both peaks as the center calculation
point. The output results were as expected.
2.4 TG-43U1 Formalism
The AAPM TG-43U1 report is recommended for dosimetry analysis of a
brachytherapy source. Until the AAPM Task Group No. 182 Report Recommendations on
Electronic Brachytherapy Quality Management is released, TG-43U1 will be used.
Figure 21 shows the polar coordinate system as defined in the report and used
here. The orientation of the Xoft source in this image is down the z-axis; the L bracket
denotes the anode location. The report defines the point of interest as P(r,θ), and the
reference point as P(r0,θ0), where r0 is 1 cm and θ0 is 90° or π/2 radians. These coordinates
and points are used to determine the radial dose function and the anisotropy function.

Figure 21. Modified TG-43U1 coordinate system for brachytherapy dose calculations.
L is the active length of the source in centimeters, r is the distance from the center of
the source to the point of interest P(r,θ) in centimeters, and θ is the polar angle
between the radius r and the longitudinal (z) axis of the source. (17)
2.4.1 Air kerma strength.
Air kerma strength SK is given in units of U, where 1 U = 1 cGy cm2/h = 1 µGy m2/h.
TG-43U1 defines SK as the air kerma rate in a vacuum due to photons of energy greater
than δ, at a distance d, multiplied by the distance squared.
𝑆𝐾 = 𝐾𝛿̇ (𝑑)𝑑2

Eqn. 4
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The distance d is defined as the distance from the source center to the point of
interest where SK is specified. The energy cutoff δ is usually set to 5 keV to exclude low
energy photons in the XOFT source emission spectrum that do not deliver significant dose
past 0.1 cm in tissue. The air kerma rate is generally measured with a free air device at
large (~1m) distances.
Air kerma strength values are reported by the manufacturer, but can also be
calibrated by an ADCL, which is traceable to the 1999 NIST standard for I-125 model
MED3631-A/M (17). However, for the Xoft source, there is no NIST standard for air kerma
strength, so the workaround calibration procedure is used.
2.4.2 Air kerma rate calibration
Because there is no NIST standard for this source, a workaround has been created
by the UWADCL by combining the procedures in TG-43U1, the task group on
brachytherapy dosimetry, and TG-61, which covers low energy (40-300 kV) x-ray beam
dosimetry.
First, the air kerma of an I-125 seed is measured in the shielded well chamber which
comes with the Xoft system, using the insert that places the seed at the “sweet spot.” The
sweet spot is defined as the point in the well chamber at which the reading from the source
is at a maximum.(14) The calibration coefficient "C" is calculated as the air kerma divided
by the corrected chamber current. Next, the Xoft source is placed in an Attix free air
chamber (FAC) and the output is measured. The ratio "R" is taken of the Xoft and I-125
coefficients, so that NSK = R x C, and NSK is defined as the Xoft air kerma in the well
chamber. This NSK value is placed in the TPS as the nominal air kerma, and is compared to
each new source's measured air kerma in the well chamber.
In clinical use, the air kerma strength of the source is measured prior to each
fraction in the attached shielded Standard Imaging well chamber, using the insert described
previously. This air kerma strength measurement, in U, is input into the TPS, which
calculates dwell time and position.
The attached well chamber is calibrated every two years by the ADCL, as per
requirements. The Xoft manual speaks of compensated air kerma, which is defined as air
kerma that is temperature and pressure corrected. The final equation for compensated air
kerma is, in units of U:
𝑆𝐾 = 𝑁𝑆𝐾 × 𝑃𝑒𝑙𝑒𝑐 × 𝑀𝑟𝑎𝑤 × 𝐶𝑇,𝑃 × 𝑃𝑎𝑙𝑡𝑖𝑡𝑢𝑑𝑒

Eqn. 5

2.4.3 Dose rate
The 2D dose rate to water equation as specified in TG-43U1 is
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𝐷̇ (𝑟, 𝜃) = 𝑆𝐾 × Λ ×

𝐺𝐿 (𝑟, 𝜃)
× 𝑔𝐿 (𝑟) × 𝐹(𝑟, 𝜃)
𝐺𝐿 (𝑟0 , 𝜃0 )

Eqn. 6

However, for this experiment, Gp(r,θ) and gp(r) are used, as was done in the Rivard et al.
paper (1). This formalism assumes that the source has a cylindrically symmetric dose
distribution with respect to the z-axis, and that the radiation emanates from a point source.
Dose rate is in units of cGy per hour. The dose rate in PRESAGE was calculated using this
equation and the tables in the Xoft manual (24). These tables are located in Appendix A. All
dosimeters were irradiated to the same dose, so all dosimeters have the same calculated
dose rate. The calculated dose rate for the PRESAGE irradiations was
𝐷̇ (1 𝑐𝑚, 90°) = 126095 𝑈 × 0.709 𝑐𝐺𝑦 ℎ−1 𝑈−1 × 1 × 1 × 1 = 894 𝐺𝑦 ℎ−1

Eqn.7

2.4.4 Dose rate constant
TG-43U1 defines the dose rate constant in water (Λ) as the ratio of the dose rate at
the reference point to the air kerma strength.
Λ=

𝐷̇ (𝑟0 , 𝜃0 )
𝑆𝐾

Eqn. 8

Λ has units of cGy per hour per U. The dose rate constant for Xoft was measured in both
solid and liquid water, as well as calculated using a Monte Carlo model. The unfiltered
source dose rate constant was not published in Rivard et al. (1), and so is taken from the
Xoft Operator’s Manual.
Dose Rate Constant (cGy hr-1 U-1)
Unfiltered 50 kV source

0.709

Table 3. Dose rate constant (24)

2.4.5 Geometry function
According to TG-43U1, the geometry function provides an inverse square law
correction based on the approximate spatial distribution of radioactivity in the source.
Therefore, there is both a point source and a line source approximation. The effective
length Leff of the anode in the Xoft source is 0.1 cm. Rivard et al. (1) states that at this small
Leff, the difference between using the line source approximation and the point source
approximation is not more than 1%, therefore they set Leff = 0, and use the point source
approximation for the geometry function. As this paper is comparing its results to that
paper, the same steps will be taken here. Therefore, the geometry function G p(r,θ) is 1/r2 or
(r0/r)2, where r and r0 are defined as before.
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Radius (cm)

1

2

3

4

5

Gp(r)

1

4

9

16

25

Table 4. Geometry factors for a point source.
2.4.6 Anisotropy function
TG-43U1 defines the 2D anisotropy function F(r,θ) as the variation in dose as a
function of polar angle relative to the transverse plane (i.e., at θ=90°). The equation is
𝐹(𝑟, 𝜃) =

𝐷̇ (𝑟, 𝜃) 𝐺𝐿 (𝑟, 𝜃0 )
𝐷̇ (𝑟, 𝜃0 ) 𝐺𝐿 (𝑟, 𝜃)

Eqn. 9

F(r0,θ0) = 1, and will decrease as r decreases, as θ approaches 0° or 180°, as
encapsulation thickness increases, or as photon energy decreases. For this experiment, to
match the Rivard et al. data (1), the point source geometry function Gp(r,θ) was used. The
values for the anisotropy function for Xoft are shown in the table below, taken from the
Rivard et al. paper. (1, 24)
θ(degrees)

F(2,θ)

F(3,θ)

F(5,θ)

0

0.993

1.018

1.050

10

1.001

1.027

1.054

20

1.013

1.037

1.059

30

1.024

1.042

1.065

40

1.052

1.065

1.075

50

1.072

1.080

1.080

60

1.075

1.079

1.075

70

1.063

1.065

1.062

80

1.037

1.038

1.036

90

1.000

1.000

1.000

100

0.953

0.954

0.950

110

0.895

0.896

0.894

120

0.820

0.824

0.825

130

0.709

0.721

0.731

140

0.564

0.590

0.616

0.426

0.473

150
160

0.364
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Table 5. Measured anisotropy function at 50 kV (1)
The anisotropy function in PRESAGE was calculated using the above equation,
which reduces to
𝐹(𝑟, 𝜃) =

𝐷̇ (𝑟, 𝜃)
𝐷̇ (𝑟, 90°)

Eqn. 10

The dose rate values were pulled from the data using the script, as described in the Data
Acquisition section. The dose rate values were corrected for zero dose as described in
Chapter 3.
2.4.7 Radial Dose Function
The radial dose function gp(r) accounts for dose falloff due to attenuation and
scattering; this does not include dose falloff from the inverse square law, since that is
already accounted for in the geometry function. The equation for a point source (1D) is
𝑔𝑝 (𝑟) =

𝐷̇ (𝑟, 𝜃0 ) 𝐺𝑝 (𝑟0 , 𝜃0 )
𝐷̇ (𝑟0 , 𝜃0 ) 𝐺𝑝 (𝑟, 𝜃0 )

Eqn. 11

Below are the values from Rivard et al. (1).

r (cm)

gp(r )

1.0

1.000

1.2

0.920

1.4

0.848

1.6

0.786

1.8

0.732

2.0

0.683

3.0

0.511

4.0

0.399

5.0

0.317

Table 6. Radial dose function values measured at 50 kV (1)
The radial dose function in PRESAGE is calculated using the equation above, which
reduces to
𝑔𝑝 (𝑟) =

𝐷̇ (𝑟, 90°) × 𝑟 2
𝐷̇ (1,90°)

Eqn. 12

The dose rate values were pulled from the data using the script, as described in the Data
Acquisition section. The dose rate values were corrected for zero dose as described in

33

Chapter 3. Note that for the radial dose function, the measurements are taken at different
radii, but all in the transverse (θ = 90°) plane.
3 Results for Xoft Source
3.1 Soft Dosimeter Batch
The soft PRESAGETM dosimeters were excluded from the results. The formulation
was created so it would fade over time after irradiation, and it was observed that in the short
time between irradiation with Xoft at the UWADCL and the post-irradiation scan at IROCHouston, the signal in the soft dosimeters faded too much to provide useful dose
information. Figure 22 shows the pre-irradiation and post-irradiation images for comparison.
It is also noted here that the Xoft source formed an electric arc during each irradiation of a
soft dosimeter, but not during any of the hard dosimeter irradiations. This was thought to be
a random effect, the only result of which was the soft dosimeter irradiations were then
forced to be delivered in a fractionated manner, e.g., one 120 second irradiation followed by
a 60 second irradiation, instead of one 180 second irradiation.
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Figure 22. Prescan and postscan images of a soft dosimeter with a large channel.
Note that the irradiation seems to have had almost no effect on the dosimeter,
probably due to fading.
3.2 Radial dose function
The radial dose function measured and calculated in PRESAGE is shown in Table
7. This data is taken from a single small channel dosimeter; the average radial dose
function data from all four dosimeters is shown in Appendix C. PRESAGE measurements at
4 cm radius were removed from the analysis due to the negligible level of signal above the
background that existed there; no data was expected at r = 5 cm due to the size of the
dosimeters and edge effects. The PRESAGE-measured radial dose functions for r = 1 cm
to r = 2 cm agree with those calculated by and Rivard et al. (1) to within 6%. However, at r =
3 cm, the radial dose function measured in PRESAGE shows an under-response by 51.1%;
this suggests that the noise level at r = 3 cm is comparable to the measureable dose at that
radius, probably due to the age of the dosimeter during its final scan and the exacerbation
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of edge effects in PRESAGE as the dosimeter ages. A graphical representation of the radial
dose function comparison is shown in Figure 23.

1

Rivard
et al.
value
1

1.2

r (cm)

PRESAGE Percent
value
Error
1

0

0.920

0.958

4.2

1.4

0.848

0.894

5.5

1.6

0.786

0.831

5.7

1.8

0.732

0.751

2.6

2

0.683

0.689

0.9

3

0.511

0.250

51.1

Table 7. Radial Dose Function Comparison

Radial Dose Function

Comparison of Radial Dose
Function
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0

PRESAGE
Rivard et al.

0

1

2
Radius (cm)

3

4

Figure 23. Graphical comparison of the radial dose function. Rivard et al. is in blue
diamonds, and PRESAGE is in red squares.
3.3 Anisotropy function
Table 8 shows the anisotropy function measured and calculated in PRESAGE.
Refer to Table 5 for the Rivard et al. anisotropy function values. The data from PRESAGE
at r = 5 cm was not included because no data is expected at that radius, due to the size of
the dosimeter and edge effects of PRESAGE. The angles 140° and 160° are very close to
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the channel, subjecting the readings there to edge effects. Table 9 shows the percent error
values for the anisotropy function, comparing the Rivard et al. (1) values to the PRESAGE
values.
θ°/r(cm)

2

3

0

1.260

1.371

10

1.202

1.239

20

1.193

1.315

30

1.280

1.264

40

1.307

1.266

50

1.285

1.299

60

1.346

1.261

70

1.316

1.224

80

1.196

1.137

90

1.000

1.000

100

0.864

0.930

110

0.693

0.835

120

0.641

0.708

130

0.832

0.631

140

1.316

0.542

150

1.029

2.154

160

1.231

4.970

Table 8. Anisotropy function measured in PRESAGE

Ignoring the extreme outlier for each radius (θ=140° for r=2, and θ=150° for r=3), the
r = 2 cm values are within 27% of the Rivard et al. data, and the r = 3 cm values are within
35% of the Rivard et al. data.
θ°/r(cm)

2

3

0

26.9

34.6

10

20.1

20.6

20

17.8

26.8

30

25.0

21.3
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40

24.3

18.9

50

19.9

20.3

60

25.2

16.8

70

23.8

14.9

80

15.4

9.5

90

0.0

0.0

100

9.3

2.5

110

22.6

6.8

120

21.9

14.1

130

17.3

12.5

140

133.3

8.2

150

405.6

160
Table 9. Anisotropy function: Percent Error

Table 10 shows the standard deviation and Table 11 shows the coefficient of
variance expressed as a percent for the PRESAGE anisotropy function data. These values
are lower closer to θ = 90°, and increase as θ moves away from the transverse plane. This
suggests that the measurements taken closest to the source are the most accurate;
measurements in PRESAGE of the dose distribution from the Xoft appear to have a more
rapid falloff than expected at large radii and at polar angles further from the transverse
plane.
θ°/r(cm)

2

3

0

0.589

0.375

10

0.557

0.349

20

0.516

0.342

30

0.514

0.322

40

0.445

0.271

50

0.360

0.223

60

0.358

0.127

70

0.345

0.060

80

0.162

0.038
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90

0.000

0.000

100

0.090

0.046

110

0.153

0.115

120

0.127

0.079

130

0.339

0.166

140

1.361

0.238

150

1.043

2.025

160

1.112

7.074

Table 10. PRESAGE Anisotropy function: Standard Deviation
θ°/r(cm)

2

3

0

46.8

27.4

10

46.3

28.1

20

43.2

26.0

30

40.2

25.5

40

34.0

21.4

50

28.0

17.2

60

26.6

10.1

70

26.2

4.9

80

13.5

3.3

90

0.0

0.0

100

10.4

4.9

110

22.1

13.8

120

19.9

11.2

130

40.7

26.3

140

103.4

43.9

150

101.3

94.0

160

90.4

142.3

Table 11. PRESAGE Anisotropy Function: Percent Coefficient of Variance
Figures 24 and 25 plot the anisotropy function at both radii and compare the Rivard
et al. values with the PRESAGE values.
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r=2 cm
Anisotropy Function

2.500
2.000
1.500
PRESAGE

1.000

Rivard et al.
0.500
0.000
0

30

60
90
120
Polar Angle (degrees)

150

Figure 24. Anisotropy function for r=2cm.

r=3cm
2.500

Anisotropy Function

2.000

1.500
PRESAGE value
1.000

Rivard et al. value

0.500

0.000
0

30
60
90
120
Polar Angle (degrees)

150

Figure 25. Anisotropy function for r=3cm.

4 Discussion
4.1 Concentric Rings Artifact
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During the initial data analysis process, concentric rings were seen in the final data
images; an example of this artifact is shown in Figure 26. These artifacts varied in
thickness, brightness, and location, but were centered in the dosimeter and not around the
channel, as might have been expected. These artifacts made the data past a radius of ~3
cm in the dosimeters unusable. An investigation was undertaken to determine the artifacts’
cause and possible solutions.

Figure 26. Reconstructed image showing the concentric ring artifact which is
centered in the dosimeter and not around the dosimeter’s channel.
The floods and dark images were checked to determine if there were any streaks
that could be causing the rings. Different center of rotation (COR) columns were used in the
image reconstructions as an inappropriate COR can cause the appearance of rings. A stray
light correction was performed. Different floods were taken and used to reconstruct the
images again. Pre-irradiation and post-irradiation scans were reconstructed separately and
inspected. The rings appeared in both sets of images, though the appearance of the rings
differed in each image; an example of these results is shown in Figure 27. The postirradiation scan was repeated and reconstructed for each dosimeter, but the rings
remained. Two unirradiated dosimeters were scanned, one from each batch, then
reconstructed as pre-irradiation scans only. The artifacts were visible in those images as
well. No other lab group members had seen these concentric rings in any current or
previous data, and no one had used the same PRESAGETM batches as were used here. A
literature search was done, but the only concentric ring artifacts found were in gel
dosimeters, and the causes of which did not apply to PRESAGE dosimetry (47, 48).
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Figure 27. Top row shows pre-irradiation scans of two different dosimeters. Bottom
row shows post-irradiation scans of two other dosimeters. Note the differing
appearance of the rings in each image.
Finally, a query was sent to Titania Juang at Duke University. By looking at the
number of counts per pixel in the RAW images, she determined that the flood and the
projection images had been taken at different shutter values. The projection images were
taken at a much higher shutter value than the flood, so that when the flood was used to
correct the projection images during reconstruction, negative counts resulted in the final
image. The flood image was darker than the dosimeter in the projection image, and had
counts that were ~1000 lower than the projection images’ counts; this can be seen in Figure
28.
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Figure 28. Projection image on left with Index (counts) of 4095. Flood image on right
with Index at same location as in projection image of 644.9, giving a delta of over
3000.
This count difference was confirmed. Since the issue was with the projection
images, which could not be retaken due to time constraints, the RAW projection images
were pulled into MATLAB. MATLAB’s image processing tools were explored as a possible
solution. A post-irradiation projection image was darkened using the ‘brighten(-0.5)’
command. The new image, seen in Figure 29, showed that there was no data outside a
radius of approximately 3 cm because the dosimeter there had been washed out by so
much light due to the high shutter value. The same was done to a pre-irradiation projection
image with the same result. In these darkened images, the cause of the concentric rings
could be seen. It is theorized that the cause of the rings is the non-homogeneous light field
of the IROC-Houston DMOS. It was already known that the field was darker in the center
and brighter at the edges, but now images of how the light field brightness changes with
radius show this inhomogeneity in more detail. This phenomenon had not been seen until
now because other lab members used the correct shutter setting and did not use such large
dosimeters as were used here. Since image processing could not improve the amount of
data available in the images, another solution was attempted.
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Figure 29. The extent of the available data (300-900 on the x-scale) can be seen in
this darkened image of a post-irradiation scan projection image. Also seen are the
causes of the concentric rings in the reconstruction images (bands of different
contrast at 200, 300, 800, and 900 on the x-scale).
4.2 Solution to Remove the Artifact
The post-irradiation scans for the hard dosimeters were retaken with the correct shutter
setting; an example projection image is shown in Figure 30, and compared to a flood image
taken at the same shutter value. In Figure 31 is an image showing the absence of artifacts
in the retaken image. The shutter setting was not discussed in the RPC DMOS Scanning
Guide (39) and had been left out of lab member training. This issue has now been
remedied. The scans were reconstructed as post-irradiation scans only, since the preirradiation scans could not be retaken. The data analysis was performed using these
reconstructed post-irradiation scans. However, since these post-irradiation scans were
performed 2 months after the irradiation, the dosimeters have aged. Older dosimeters are
darker overall, and the radiation signal faded. Furthermore, edge effects are exacerbated in
older dosimeters. The data obtained from the new post-irradiation scans will be subject to
these age effects, and will not compare well with the Rivard et al. (1) data.
However, since the “post scan” only reconstruction was performed, no subtraction of
background OD value in the dosimeter was completed. To remedy this, the dose rates at
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large radii for each dosimeter were plotted and a background value was chosen at the point
where the data appeared to level out in the plot. This background value was then
subtracted from all dose rates. An example of this plot is shown in Figure 32.

Figure 300. Projection image on left with Index 3692. Flood image on right with Index
at same location as in projection image of 3964, giving a delta of less than 30.

Figure 311. Final post-irradiation scan of a dosimeter showing no ring artifact. The
rings seen in this image relate to the dose at various radii.
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Dose Rate from PRESAGE

Background Level
0.0500
0.0450
0.0400
0.0350
0.0300
0.0250
0.0200
0.0150
0.0100
0.0050
0.0000
3

3.5

4
r (cm)

4.5

5

Figure 322. Example background level plot. The background value selected for this
dosimeter was 0.0150.
4.2.1 Dose Rate and Dose Rate Constant
Due to this background subtraction correction and the unavailability of applicable
cuvette dose calibration curves, the doses reported are relative to each dosimeter.
Therefore, the dose rate and dose rate constants were not calculated for comparison.
5 Uncertainty Analysis
TG-43U1 (17) recommends a generic uncertainty analysis for dosimetric quantities
measured and calculated for brachytherapy sources. TG-138 (49) outlines a procedure for
this analysis. Table 12 contains a summary of Type A (k=1) and Type B (k=1) uncertainties
as well as an estimation of the expanded relative uncertainty (k=2), which is defined as a
95% confidence limit. The total standard uncertainty (k=1) for the dose rates measured in
PRESAGE was estimated to be 5.7%, and the expanded uncertainty (k=2) was 11.4%.
The Type A, or statistical, uncertainties in this experiment were all related to the
measurements taken in PRESAGE, for both the radial dose function and the anisotropy
function. These uncertainties were calculated as the uncertainty in the dose rate at a
selected radius (or radius and polar angle) and the uncertainty in the dose rate at the
reference point, added in quadrature. The uncertainties in the dose rates were calculated
as a percent coefficient of variance. An example for a selected radius and polar angle will
be presented in the sections that follow. There were several Type B, or random,
uncertainties in this experiment. First, the uncertainty of the air kerma strength measured at
the UWADCL includes the equipment used to make the measurement and the
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reproducibility of the measurement; this was estimated to be 5% (k=1). The uncertainty in
the current and voltage supplies used to run the Xoft source was estimated to be less than
1%. Since the anode in the Xoft source is not a point source but has a finite and
measureable thickness, this introduces 1.5% uncertainty into the experiment. PRESAGETM
is not exactly water-equivalent, as discussed previously, and so this introduces an
estimated 2% uncertainty into the experiment.
The total standard uncertainty is the quadrature sum of all the listed uncertainty
components, and the expanded relative uncertainty is simply twice that value.

Uncertainty Component

Type A (k=1) Type B (k=1)

Xoft air kerma strength (UWADCL)

5.0%

Current, voltage uncertainty

<1.0%

Anode thickness

1.5%

Water-equivalency of PRESAGE

2.0%

Total standard uncertainty (k=1)

5.7%

Expanded relative uncertainty (k=2)

11.4%

Table 12. Uncertainty in PRESAGE measurement of Dose Rate
5.1 Anisotropy function
The anisotropy function is a ratio between two dose rates. Therefore, uncertainty in
the Xoft air kerma strength measurement will cancel out. The uncertainty in current will
cancel out as well, leaving the voltage uncertainty as <1%, which will be ignored. The Type
A uncertainty at a radius of 3 cm and a polar angle of 60° is 64.4%. This large uncertainty in
the measurement dominates the uncertainty estimate for the anisotropy function. Thus, the
total uncertainty (k=1) for the anisotropy function is 64.4%, and the expanded uncertainty
(k=2) is 128.9%.
5.2 Radial dose function
The radial dose function is also a ratio of two dose rates, so the Xoft air kerma
strength measurement and tube current uncertainties cancel out here as well, and the
uncertainty in the voltage can be ignored as before. The Type A uncertainty at a radius of 2
cm is 29.5%. Therefore, the total uncertainty (k=1) is 29.6% and the expanded uncertainty
(k=2) is 59.2%.
6 Conclusion
The hypothesis for this project was rejected. The PRESAGETM dosimeters were not
able to measure, with 95% confidence, the AAPM TG-43U1 dosimetric parameters of the
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Xoft Axxent electronic brachytherapy source, to within ±5%/3mm of Rivard’s published
values.
Despite errors in methodology, the radial dose and anisotropy functions were more
accurate closer to the source. The radial dose function from r=1 cm to r=2 cm was within
6% of expected values. The anisotropy function for θ=90°±10° was within 16% of the
accepted values for r=2 cm and within 10% for r=3 cm. The experiment should be repeated.
To improve this experiment, a new batch of hard dosimeters, containing three of
each channel size, should be irradiated using the Xoft source. The pre-irradiation scans,
post-irradiation scans, and flood images should all be taken at the same and correct shutter
value. Prior to shipping the dosimeters to the UWADCL for irradiations, the pre-irradiation
scans should be reconstructed and viewed to ensure the images are “clean” and will
provide acceptable data. A dose calibration should be performed by irradiating 10 cuvettes
from the same batch as the dosimeters on the 75 kVp orthovoltage machine; the doses
delivered should range from 0 Gy to 18 Gy. When irradiating the small channel dosimeters,
a dose larger than 15 Gy may be given to ensure the OD at r = 5 cm is detectable.
As for future work, it would be greatly useful to the lab group, especially future
members, to have the cuvette irradiation procedures written out for both orthovoltage and
MV linear accelerator machines. The DMOS Scanning Guide should also be updated with a
checklist for use during each scan, as well as further explanations on what each scanning
parameter controls, how it can be adjusted, and when it should be adjusted. A procedure on
how to adjust the matching fluid, including images for comparison, should be written and
included in the lab group’s training materials. PRESAGE dose calibration data for each
batch should be kept in a lab group shared folder for all to reference. The effects of age on
a dosimeter, in relation to edge effects, should be further investigated. The two scripts
written for this project could be updated to output the standard deviation for the average
dose rate calculated for each input dose cube.
This project’s findings illustrate the pitfalls of PRESAGE dosimetry, and the need for
accurate and thorough training documents. However, PRESAGE remains a viable method
to conduct 3D brachytherapy dosimetry, which could greatly improve the understanding of
dose distributions for new brachytherapy sources as they are developed, as well as
advance quality assurance methods. Future work in dosimetry including the use of
brachytherapy applicators in anthropomorphic PRESAGE may begin a new chapter in 3D
dosimetry.
Appendix A
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Xoft Source TG-43 Parameter Tables (24)

Dose Rate Constant
Dose Rate Constant (cGy hr-1 U-1)
Unfiltered 50 kV source

0.709

Radial Dose Function g(r)
Radius (cm) Dose Function
0.5

1.418

1.0

1.000

1.5

0.780

2.0

0.641

3.0

0.470

4.0

0.362

5.0

0.286

6.0

0.229

7.0

0.185

8.0

0.150

9.0

0.122

10.0

0.0989

12.0

0.0655

15.0

0.0352

Anisotropy Function F(r, θ)
Angle (degrees)
Radius

0

5

10

15

20

25

30

35

40

45

50

55

60

0.5

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.252

0.425

0.556

0.676

0.743

0.796

1.0

0.000

0.000

0.000

0.241

0.211

0.211

0.301

0.380

0.483

0.575

0.667

0.738

0.800

1.5

0.000

0.000

0.248

0.267

0.258

0.274

0.361

0.435

0.530

0.609

0.689

0.750

0.811

2.0

0.000

0.000

0.272

0.297

0.298

0.322

0.405

0.476

0.564

0.637

0.709

0.765

0.820

3.0

0.000

0.250

0.296

0.319

0.327

0.357

.0426

0.508

0.590

0.656

0.721

0.773

0.824

4.0

0.000

0.279

0.321

0.343

0.356

0.389

0.450

0.526

0.603

0.665

0.726

0.775

0.825

5.0

0.000

0.290

0.329

0.349

0.364

0.419

0.473

0.545

0.616

0.674

0.731

0.778

0.825

(cm)
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6.0

0.000

0.313

0.349

0.369

0.385

0.424

0.489

0.562

0.626

0.681

0.737

0.782

0.828

7.0

0.000

0.334

0.365

0.383

0.406

0.429

0.504

0.579

0.636

0.692

0.743

0.794

0.830

8.0

0.000

0.349

0.377

0.397

0.420

0.441

0.515

0.589

0.643

0.698

0.747

0.797

0.831

10.0

0.000

0.371

0.395

0.412

0.439

0.459

0.531

0.604

0.657

0.707

0.753

0.800

0.832

12.0

0.000

0.384

0.407

0.426

0.454

0.473

0.542

0.613

0.663

0.712

0.757

0.801

0.831

15.0

0.000

0.401

0.417

0.437

0.465

0.482

0.550

0.622

0.667

0.715

0.758

0.801

0.831

Anisotropy Function F(r, θ) (continued)
Angle (degrees)
Radius

65

70

75

80

85

90

95

100

105

110

115

120

0.5

0.840

0.883

0.914

0.945

0.970

1.000

1.021

1.041

1.053

1.063

1.065

1.064

1.0

0.840

0.884

0.916

0.948

0.973

1.000

1.020

1.040

1.053

1.065

1.069

1.072

1.5

0.849

0.890

0.920

0.950

0.975

1.000

1.020

1.038

1.052

1.064

1.069

1.074

2.0

0.858

0.895

0.924

0.953

0.977

1.000

1.019

1.037

1.050

1.063

1.069

1.075

3.0

0.860

0.896

0.925

0.954

0.977

1.000

1.019

1.038

1.052

1.065

1.072

1.079

4.0

0.860

0.895

0.924

0.952

0.976

1.000

1.019

1.037

1.050

1.064

1.070

1.077

5.0

0.860

0.894

0.922

0.950

0.975

1.000

1.018

1.036

1.049

1.062

1.069

1.075

6.0

0.862

0.896

0.924

0.952

0.976

1.000

1.019

1.037

1.051

1.064

1.071

1.078

7.0

0.866

0.898

0.929

0.954

0.979

1.000

1.021

1.039

1.056

1.066

1.076

1.081

8.0

0.865

0.898

0.927

0.953

0.979

1.000

1.022

1.039

1.056

1.066

1.076

1.082

10.0

0.866

0.898

0.927

0.952

0.978

1.000

1.021

1.039

1.055

1.066

1.078

1.083

12.0

0.866

0.897

0.926

0.952

0.977

1.000

1.020

1.039

1.056

1.068

1.077

1.089

15.0

0.865

0.895

0.925

0.951

0.977

1.000

1.022

1.039

1.057

1.071

1.083

1.093

(cm)

Anisotropy Function F(r, θ) (continued)
Angle (degrees)
Radius

125

130

135

140

145

150

155

160

165

170

175

180

0.5

1.057

1.048

1.028

0.997

0.968

0.944

0.907

0.902

0.893

0.890

0.892

0.887

1.0

1.067

1.062

1.044

1.027

1.005

0.980

0.967

0.960

0.954

0.948

0.947

0.940

1.5

1.072

1.068

1.055

1.042

1.025

1.006

0.998

0.992

0.986

0.980

0.974

0.969

2.0

1.074

1.072

1.062

1.052

1.038

1.024

1.019

1.013

1.007

1.001

0.997

0.993

3.0

1.080

1.080

1.073

1.065

1.054

1.042

1.040

1.037

1.032

1.027

1.023

1.018

4.0

1.079

1.080

1.075

1.070

1.062

1.054

1.051

1.048

1.044

1.041

1.037

1.034

5.0

1.078

1.080

1.078

1.075

1.070

1.065

1.062

1.059

1.057

1.054

1.052

1.050

(cm)
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6.0

1.081

1.083

1.081

1.080

1.077

1.073

1.071

1.069

1.066

1.064

1.064

1.064

7.0

1.086

1.086

1.086

1.085

1.083

1.082

1.080

1.078

1.076

1.075

1.073

1.079

8.0

1.090

1.087

1.088

1.088

1.090

1.084

1.084

1.085

1.080

1.079

1.081

1.080

10.0

1.091

1.091

1.092

1.094

1.097

1.096

1.092

1.092

1.089

1.087

1.093

1.090

12.0

1.094

1.094

1.097

1.098

1.105

1.103

1.101

1.101

1.097

1.097

1.102

1.095

15.0

1.101

1.101

1.105

1.106

1.113

1.111

1.110

1.109

1.107

1.107

1.105

1.110

Appendix B
Radialunicorns.m Code
%radialunicorns by sierra
%purpose of this code is currently to spit out average dose/OD values from
%input data cubes at various radii from a center point entered by the user
%for use in TG-43U1 radial dose fcn
clear;
clc;
%input data cube, either manually, or in prompt
% [filename,pathname] = uigetfile('*.mat','PROMPT TEXT HERE');
% load([pathname,filename]);
load('S:\SHARED\Radiation physics\Slade\Top Secret Unicorn Data\8-1012Bnew data cube.mat');
%load('C:\Users\jsirwin\Desktop\IMPORTANT DATA CUBES\ss2 data cube.mat');
%enter center coordinates
% cx=0;
% cy=0;
% cz=0;
% cx = input('Enter center x coordinate: ');
% cy = input('Enter center y coordinate: ');
% cz = input('Enter center z coordinate: ');
cx=71;
cy=72;
cz=114;
zsmall=0;
zbig=0;
zsmall=cz-1;
zbig=cz+1;
%enter extent of x, y, z coordinates for use in calculation
% xmax=0;
% ymax=0;
% zmax=0;
% xmax = input('Enter maximum x coordinate: ');
% ymax = input('Enter maximum y coordinate: ');
% zmax = input('Enter maximum z coordinate: ');
xmax=140;
ymax=140;
zmax=151;

51

%set real radii to loop through, along with annulus radii (delta from
real)
r=0;
R=0;
delta=0;
radius=[10:2:70]; %radius in mm
num_radii = length(radius); %so can spit out pixelcount & average as
arrays
delta=.5;
r=radius-delta;
R=radius+delta;
%code to ensure that "negative" dose is set to zero dose
Negativeindicies=find(ReconstructedSlices.cube<0);
ReconstructedSlices.cube(Negativeindicies)=0;
%search for pixels within annulus then adds them up for statistics
analysis
%also computes average value at pixel (sum) for OD/DOSE output
%borrowed from slade's phoenixfire code
Sum=zeros(1,num_radii);
Average=zeros(1,num_radii);
PixelCount=zeros(1,num_radii);
for i=1:num_radii
for z=zsmall:zbig
for x=1:xmax
for y=1:ymax
if (r(i)<(sqrt((cx-x)^2 + (cy-y)^2)) && (sqrt((cx-x)^2 +
(cy-y)^2)<R(i)))
Sum(i)=Sum(i) + ReconstructedSlices.cube(x,y,z);
PixelCount(i)=PixelCount(i)+1;
end
end
end
end
Average(i)=Sum(i)/PixelCount(i);
end
%this section exports my data to an excel file
%asks where you want to save the excel file, and what to call it
[fileName, pathName]=uiputfile('*.xlsx','Export Profile');
%changes my 3 data arrays into vertical cells & creates one big matrix
data=num2cell([radius; Average; PixelCount]');
%name each column of my data cells
titles = {'Radius', 'Average Dose', 'Pixel Count'};
%place correct title at top of correct data column (cat two things
together)
dataout=cat(1,titles,data);
%writes to the designated file the concatenated matrix i created above
xlswrite(fullfile(pathName,fileName),dataout);

Anisotropyunicorns.m Code
%anisotropyunicorns by sierra
%purpose of this code is currently to spit out average dose/OD values from
%input data cubes at various radii and angles from a center point entered
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%by the user for use in TG-43U1 anisotropy fcn
clear;
clc;
%input data cube;
%[filename,pathname] = uigetfile('*.mat','Enter data cube file location:
');
% load([pathname,filename]); %to load file from prompt
%load('C:\Users\jsirwin\Desktop\IMPORTANT DATA CUBES\ss2 data cube.mat');
load('S:\SHARED\Radiation physics\Slade\Top Secret Unicorn Data\8-1012Bnew data cube.mat');
%enter center coordinates
% cx=0;
% cy=0;
% cz=0;
% cx = input('Enter center x coordinate: ');
% cy = input('Enter center y coordinate: ');
% cz = input('Enter center z coordinate: ');
cx=71;
cy=72;
cz=114;
%enter extent of x, y, z coordinates for use in calculation
% xmax=0;
% ymax=0;
% zmax=0;
% xmax = input('Enter maximum x coordinate: ');
% ymax = input('Enter maximum y coordinate: ');
% zmax = input('Enter maximum z coordinate: ');
xmax=140;
ymax=140;
zmax=151;
%define all my radius, delta, and angle variables outside for loop
theta = [0:10:160];
thetaradians = zeros(size(theta));
radius = [10, 20, 30, 40, 50]; %radius in mm; added 10 for checks, 40 just
b/c
num_radii = length(radius); %get number of radii checking
thetaradians = theta*pi()/180;
num_radian = length(thetaradians); %get number of angles checking
delta = 0;
r = 0;
R = 0;
zsmall=0;
zbig=0;
delta = .5; %in mm
%code to ensure that "negative" dose is set to zero dose
Negativeindicies=find(ReconstructedSlices.cube<0);
ReconstructedSlices.cube(Negativeindicies)=0;
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%set up variables to be matrices of size radii by angle, for ease of
output
Average=zeros(num_radii,num_radian);
PixelCount=zeros(num_radii,num_radian);
Sum=zeros(num_radii,num_radian);
for radiusloop = 1:num_radii
for radianloop=1:num_radian
%define reff in terms of (r, theta)
reff = radius(radiusloop) * sin(thetaradians(radianloop));
%calculate delta z from center z coordinate for each reff
deltaz = radius(radiusloop) * cos(thetaradians(radianloop));
%apply delta z to center z coordinate correctly
zeff = cz + deltaz;
%define inner/outer effective radii
r = reff - delta;
R = reff + delta;
%define z planes to look at. +/-1 seemed like a better choice
zsmall=round(zeff-1);
zbig=round(zeff+1);
%search for pixels within annulus then adds them up for statistics
analysis
%also computes average value at pixel (sum) for OD/DOSE output
%borrowed from slade's phoenixfire code
for z=max(1,zsmall):min(zmax,zbig) %so doesn't go outside cube
coordinates
for x=1:xmax
for y=1:ymax
if ((r<(sqrt((cx-x)^2 + (cy-y)^2))) && (sqrt((cx-x)^2 +
(cy-y)^2))<R)
Sum(radiusloop,radianloop)=Sum(radiusloop,radianloop) +
ReconstructedSlices.cube(x,y,z);
PixelCount(radiusloop,radianloop)=PixelCount(radiusloop,radianloop)+1;
end
end
end
end
Average(radiusloop,
radianloop)=Sum(radiusloop,radianloop)/PixelCount(radiusloop,radianloop);
end
end
%this section exports my data to an excel file
%asks where you want to save the excel file, and what to call it
[fileName, pathName]=uiputfile('*.xlsx','Export Profile');
%assembling arrays into matrices x 2
dataradius=num2cell(radius');
title={'Radius/Angle'};
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radiusdata=cat(1,title,dataradius);
avgdata=num2cell([theta; Average]);
countdata=num2cell([theta; PixelCount]);
data1=cat(2,radiusdata,avgdata);
data2=cat(2,radiusdata,countdata);
%writes to the designated file & sheet# the 2 matrices i created above
sheet=1;
xlswrite(fullfile(pathName,fileName),data1,sheet);
sheet=2;
xlswrite(fullfile(pathName,fileName),data2,sheet);

Appendix C
Radial Dose Function Comparison Data for the Average of all four dosimeters.

1

Rivard
et al.
values
1

1.2

r (cm)

PRESAGE Standard
values
Deviation

COV
(%)

Percent
Error

1

0

0

0

0.920

1.022

0.354

34.6

11.1

1.4

0.848

1.091

0.564

51.7

28.6

1.6

0.786

1.000

0.656

65.6

27.2

1.8

0.732

0.831

0.614

73.9

13.5

2

0.683

0.688

0.501

72.8

0.7

3

0.511

0.191

0.187

98.0

62.6
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